Absolute Antibody's murine bispecific reagents enable researchers and drug developers to more easily evaluate potential bispecific combinations in mouse models.
The Anti-Alpaca secondary antibody product line targets the IgG repertoire of camelid immunoglobulins, including whole molecule, subclass and VHH domain specificities. They are raised against alpaca and cross-react with llama.
Scientists have developed a new antibody technology that combines the advantages of antibody-based therapies with the convenience of oral drug administration.
Leica Biosystems' PD-L1 BOND antibody is designed for use on their fully automated BOND IHC and ISH staining platform.
The scientific community is currently facing a reproducibility crisis. Over 70% of researchers are failing to reproduce published experiments.
Biotechnology company IONTAS has announced a panel of human antibodies that neutralise elements of black mamba snake toxin in an in vivo model.
Bio-Rad Laboratories has launched a range of recombinant monoclonal anti-ranibizumab antibodies that are highly specific for the monoclonal antibody drug ranibizumab (Lucentis) or the complex of ranibizumab with its target, vascular endothelial growth factor A (VEGF-A).
Thermo Fisher Scientific will utilise BenchSci's machine learning platform to mine antibody data published in peer-reviewed scientific journals.
The Native Antigen Company is an expert in the production of bacterial and viral antigens, specialising in the development and manufacture of native and recombinant viral and bacterial antigens.
Bio-Rad Laboratories has launched a range of anti-idiotypic antibodies targeting the immune checkpoint inhibitor drugs pembrolizumab (Keytruda) and nivolumab (Opdivo). Anti-pembrolizumab and anti-nivolumab antibodies are designed for use in bioanalytical assays to monitor the drug levels in cancer patients.
Bio-Rad's anti-vedolizumab antibodies include four recombinant monoclonal anti-idiotypic antibodies that are highly specific for the humanised IgG1 kappa antibody drug vedolizumab, and are suitable for development of bioanalytical and patient monitoring assays.
Bio-Rad Laboratories has announced the StarBright Blue 520 Fluorescent Secondary Antibodies — fluorescent dye-labelled secondary antibodies for use in multiplex western blotting.
AdipoGen Life Sciences' anti-α-Tubulin monoclonal antibodies (recombinant) are composed of human variable regions (VH and VL) (λ-chain) of immunoglobulin fused to the human lgG2 Fc domain.
EpiGentek has released a monoclonal antibody that is specific to Staphylococcus aureus Cas9 (SaCas9) and enables easy and specific monitoring of gene editing processes.
Abcam has combined the advantages of its RabMAb rabbit monoclonals with recombinant technology to deliver high-performance antibodies.